October was another busy month in Huntington’s disease (HD) research! We learned more about often-overlooked symptoms, ...
The FDA has accepted uniQure’s application for AMT-130 (now called ifezuntirgene inilparvovec), an experimental gene therapy ...
HD researchers developed an AI-powered tool that analyzes a short counting task. Its speech measures reflected clinical scores and HD-related changes over time, suggesting it could be used as a remote ...
An experimental treatment for HD developed by Alnylam has shown long-lasting huntingtin lowering after just one dose, with ...
The lines between HD and catatonia may sometimes be blurred. However, recognising that occasionally there can be more than ...
For decades, Huntington’s disease (HD) research has focused on what goes wrong inside vulnerable brain cells. But neuronsneuron Brain cells that store and transmit information don’t work alone, they ...
In plain language. Written by scientists. An experimental treatment for HD developed by Alnylam has shown long-lasting huntingtin lowering after just one dose, with encouraging early safety data. A ...
This Fall, HDBuzz is proud to launch our “Falling Into Hope” fundraising campaign. Our goal is simple but ambitious: raise $30,000 in the next 8 weeks, by October 28. 2025 will be a landmark year in ...
In an update from uniQure, they report that their experimental gene therapy, AMT-130, has the potential to slow Huntington’s disease progression in key clinical study. HD is caused by a faulty copy of ...
Researchers have updated the system that classifies Huntington’s disease progression. Tracking progression in 4 stages will make clinical trial screening and data interpretation easier and faster, and ...
A new Phase 1 study is testing SRP-1005, a huntingtin-lowering therapy given by injection under the skin. It’s early days, but this approach could add an important new arrow to the HD drug development ...
uniQure shared in a press release on June 17, 2026 that the Food and Drug AdministrationFood and Drug Administration The government regulatory authority in the US responsible for approving new drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results